Mymee
Healthcare Software · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
211 E 43rd St Fl 7 204, New York City, N...Phone Number
(917) 476-4122Website
www.mymee.comRevenue
<$5 MillionIndustry
About Mymee
Mymee Org Chart
Is Mymee your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Mymee has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Mymee, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Mymee has new funding data
Earning: See what the market has to say on Mymee recently announced quarterly report
Check out if Mymee is spiking on competitors!
Product Launch: Get notified when Mymee launches new products
Congratulate Masked Content for being promoted to Masked Content at Mymee
Click to see if Mymee had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Mymee
Compare insights from companies similar to Mymee, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mymee is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Mymee is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Mymee.
Mymee Tech Stack
A closer look at the technologies used by Mymee
Most Recent Scoops
Mymee News & Media
Mymee's Personalized Trial & Care Platform Helps Autoimmune Disease Patients Reverse Flares, New Research Shows
>85% of patients with moderate to severe symptoms at baseline achieved HRQoL improvements; severe symptoms saw largest improvements 76% were taking ≥ 1 immunosuppressant, >80% reported pain in joints & fatigue at baseline, 68% of patients enrolled in the study had comorbidities...New real-world study demonstrates connection between Long COVID and rheumatic autoimmune disease symptoms and environmental triggers
Retrospective study focused on patients who remained symptomatic despite evidence-based medicine or standard diet protocols NEW YORK, Nov. 11, 2022 /PRNewswire/ -- Mymee, Inc., a pioneer in self-evidence-based research for people who struggle with symptoms associated with long COVID and...Mymee Acquires Breakthrough Health, Leading Digital Health Platform for Multiple Sclerosis
Acquisition Includes #1 Ranked MS App in Google and Apple App Stores, Emilyn NEW YORK, July 27, 2022 /PRNewswire/ -- Mymee, a leading provider of specialized care and support for people with significant symptoms associated with autoimmune disease and long COVID, has acquired Berlin-based...Serimmune and Mymee Collaborate on Research Study to Better Define the Role of Antibodies in SARS-CoV-2 Symptoms
GOLETA, Calif.--(BUSINESS WIRE)--Serimmune, a leader in understanding the antibody repertoire's role in human disease, and Mymee, a leading provider of digital care programs for reducing persistent symptoms resulting from autoimmune disease, chronic inflammation and long haul COVID, announced today that they will collaborate on a clinical research study to describe the role antibodies play in patients suffering from COVID-19. The partnership includes collaborating on research to understand the
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mymee
Mymee is a digital care solution that specializes in identifying unique triggers for patients suffering from autoimmune diseases such as rheumatoid arthritis, lupus, psoriatic arthritis, ankylosing spondylitis, and long COVID. The company offers personalized trials and care through a proprietary method that has been clinically validated, demonstrat... Read More